Assessment of barriers to pancreatic cancer surveillance in high‐risk individuals
Open Access
- 9 October 2025
- journal article
- Published by Wiley in Journal of Genetic Counseling
- Vol. 34 (5) , e70117
Abstract
Individuals with increased familial or genetic risk of pancreatic cancer (PC) may be recommended to undergo regular PC surveillance. Genetic counselors are often involved in discussions about PC surveillance for high‐risk individuals (HRIs); however, barriers to HRIs' participation in PC surveillance are not well characterized. This study aimed to identify reasons that HRIs cease, defer, or do not commence recommended PC surveillance through telephone interviews. Participants either had prior annual PC surveillance with no surveillance completion in ≥2 years, had a ≥2‐year period without surveillance completion, or had not completed an initial surveillance imaging study 3 months after it was ordered. Fifty telephone interviews were analyzed using directed content analysis. Twenty interviewees had familial PC (34.5%) and 38 (65.5%) had a pathogenic variant associated with increased PC risk, with BRCA2 being the most common ( N = 15, 25.9%). Interviewees were 74.1% women and 93.1% White with a median age of 63.0 years. Logistical barriers ( N = 11, 34.4%), different healthcare professional recommendations ( N = 9, 28.1%), other health issues ( N = 8, 25.0%), and difficulty recalling surveillance recommendations ( N = 8, 25.0%) were the top reasons for ceasing or deferring PC surveillance. Difficulty recalling surveillance recommendations ( N = 5, 27.8%), cost ( N = 4, 22.2%), and invasiveness of procedures ( N = 4, 22.2%) were the top reasons for not commencing PC surveillance. Other reasons included the COVID‐19 pandemic, moving from the service delivery area, cost, concerns about imaging studies, nonmedical life events, and fear. Several barriers identified in this study were consistent with barriers faced in screening for other more common cancers. These results demonstrate the need for targeted strategies to reduce PC surveillance barriers for HRIs. Furthermore, given that HRIs face multiple barriers to PC surveillance, it is important that cancer genetics professionals familiarize themselves with these barriers to reduce their impact and to facilitate recommended PC surveillance among HRIs.Keywords
This publication has 27 references indexed in Scilit:
- Genetics of Familial and Sporadic Pancreatic CancerGastroenterology, 2019
- Importance of Driving and Potential Impact of Driving Cessation for Rural and Urban Older AdultsThe Journal of Rural Health, 2019
- German National Case Collection for familial pancreatic Cancer (FaPaCa) - acceptance and psychological aspects of a pancreatic cancer screening programHereditary Cancer in Clinical Practice, 2018
- Factors associated with patient recall of key information in ambulatory specialty care visits: Results of an innovative methodologyPLOS ONE, 2018
- Barriers and facilitators associated with colonoscopy completion in individuals with multiple chronic conditions: a qualitative studyPatient Preference and Adherence, 2017
- Barriers to Colorectal Cancer Screening in a Racially Diverse Population Served by a Safety-Net ClinicJournal of Community Health, 2017
- ACG Clinical Guideline: Genetic Testing and Management of Hereditary Gastrointestinal Cancer SyndromesAmerican Journal of Gastroenterology, 2015
- Familial pancreatic cancer—status quoInternational Journal of Colorectal Disease, 2013
- Traveling Towards Disease: Transportation Barriers to Health Care AccessJournal of Community Health, 2013
- Three Approaches to Qualitative Content AnalysisQualitative Health Research, 2005